The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Selumetinib (Sel) and cisplatin/gemcitabine (CisGem) for advanced biliary tract cancer (BTC): A randomized trial.
 
Mark Doherty
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca; Merck
 
Vincent C. Tam
Honoraria - Apobiologix; Celgene
Travel, Accommodations, Expenses - Amgen
 
Mairead Geraldine McNamara
Consulting or Advisory Role - Celgene; Ipsen
Research Funding - Nucana
 
David W. Hedley
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Eric Xueyu Chen
No Relationships to Disclose
 
Raymond Woo-Jun Jang
Consulting or Advisory Role - Ipsen
Research Funding - AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Patricia A. Tang
Consulting or Advisory Role - AMGEN; Celgene; Genomic Health International; Merck; Novartis Canada Pharmaceuticals Inc; Shire; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen
 
Hao-Wen Sim
No Relationships to Disclose
 
Grainne M. O'Kane
No Relationships to Disclose
 
Stephanie DeLuca
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Kelly Brooks
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca